|
2024
|
G/S
|
Diagnostic, biological and chemical reagents for scientific and research use; pharmaceutical inte... |
|
|
Invention
|
Clec9a-based chimeric protein formulations. The present application provides, in part, pharmaceut... |
|
|
Invention
|
Clec9a binding agents and use thereof.
The present invention relates, in part, to agents that bi... |
|
|
Invention
|
Sirp1a targeted chimeric proteins and uses thereof.
The present invention relates, in part, to a... |
|
|
G/S
|
Diagnostic, biological and chemical reagents for scientific and research use; Pharmaceutical inte... |
|
|
Invention
|
Fibroblast binding agents and use thereof.
The present invention relates, in part, to agents tha... |
|
2023
|
Invention
|
Il-2 trap molecules. The present disclosure provides methods of reducing, mitigating, or eliminat... |
|
2022
|
G/S
|
Diagnostic and chemical reagents for scientific and research use; pharmaceutical intermediates fo... |
|
|
Invention
|
Cd8 binding agents.
The present invention relates, in part, to agents that bind CD8 and their us... |
|
|
Invention
|
Pd-1 and pd-l1 binding agents.
The present invention relates, in part, to agents that bind PD-1 ... |
|
|
Invention
|
Split human ifn-gamma and tnf-alpha constructs and uses thereof.
The present invention relates, ... |
|
|
Invention
|
Split human ifn-gamma and tnf-alpha constructs and uses thereof. The present invention relates, i... |
|
|
Invention
|
Therapeutic interferon alpha 1 proteins.
The present invention relates, in part, to chimeric pro... |
|
|
Invention
|
Interleukin-1 alpha chimeric protein.
The present invention relates, in part, to chimeric protei... |
|
|
Invention
|
Interleukin-1 alpha chimeric protein. The present invention relates, in part, to chimeric protein... |
|
|
Invention
|
Il-2 based constructs.
The present invention relates, in part, to chimeric proteins or chimeric ... |
|
|
Invention
|
Il-2 based constructs. The present invention relates, in part, to chimeric proteins or chimeric p... |
|
2021
|
Invention
|
Immunostimulatory adjuvants.
The present invention relates, in part, to vaccine compositions, ad... |
|
|
Invention
|
Immunostimulatory adjuvants. The present invention relates, in part, to vaccine compositions, adj... |
|
2020
|
Invention
|
Targeted engineered interferon and uses thereof.
The present invention relates, in part, to chim... |
|
|
Invention
|
Detection of novel degradation-related interactions.
The present invention is related to a metho... |
|
|
Invention
|
Detection of novel degradation-related interactions. The present invention is related to a method... |
|
|
Invention
|
Compounds modulating protein recruitment and/or degradation.
The invention provides cereblon bin... |
|
|
Invention
|
Bifunctional agents for protein recruitment and/or degradation.
The disclosure relates to new co... |
|
|
Invention
|
Bifunctional agents for protein recruitment and/or degradation. The disclosure relates to new com... |
|
|
Invention
|
Compounds modulating protein recruitment and/or degradation. The invention provides cereblon bind... |
|
|
Invention
|
Detection of molecular interactions.
Methods for detection of molecular interactions, such as pr... |
|
|
Invention
|
Modulation of protein degradation.
Methods of assessing the efficacy of an agent in treating a d... |
|
|
Invention
|
Modulation of protein degradation. Methods of assessing the efficacy of an agent in treating a di... |
|
|
Invention
|
Detection of molecular interactions. Methods for detection of molecular interactions, such as pro... |
|
|
Invention
|
Pd-l1 targeted chimeric proteins and uses thereof.
The present invention relates, in part, to ag... |
|
|
Invention
|
Conjugated chimeric proteins.
The present invention relates, in part, to pegylated chimeric prot... |
|
|
Invention
|
Pd-l1 targeted chimeric proteins and uses thereof. The present invention relates, in part, to age... |
|
|
Invention
|
Conjugated chimeric proteins. The present invention relates, in part, to pegylated chimeric prote... |
|
|
G/S
|
Diagnostic and biological reagents for scientific and research use; cytokines, namely, reagents f... |
|
|
G/S
|
Cytokines, namely, reagents for scientific and research; diagnostic and biological reagents for s... |
|
|
G/S
|
Cytokines, namely, reagents for scientific and research; Diagnostic and biological reagents for s... |
|
|
Invention
|
Combination therapy with cd13-targeted chimeric proteins or chimeric protein complexes.
The pres... |
|
|
Invention
|
Fibroblast activation protein binding agents and use thereof.
The present invention relates, in ... |
|
|
Invention
|
Fms-like tyrosine kinase 3 ligand (flt3l)-based chimeric proteins.
FMS-like tyrosine kinase 3L (... |
|
|
Invention
|
Chimeric proteins and chimeric protein complexes directed to fms-like tyrosine kinase 3 (flt3).
... |
|
|
Invention
|
Clec9a-based chimeric protein complexes.
The present invention relates, in part, to chimeric pro... |
|
|
G/S
|
Diagnostic and biological reagents for scientific and research use; pharmaceutical intermediates ... |
|
2019
|
Invention
|
Particle based small molecule-protein complex trap.
The present invention relates to the use of ... |
|
|
Invention
|
Modulation of dendritic cell lineages.
The present invention relates, in part, to agents, chimer... |
|
|
Invention
|
Sirp1α targeted chimeric proteins and uses thereof. The present invention relates, in part, to ag... |
|
2018
|
Invention
|
Clec9a binding agents comprising a recombinant heavy-chain only antibody (vhh). The present inven... |
